QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=DF855E1FCDC082CA178D4759DE591992;jsessionid=CEC07D6E3BD976C0A49BA3484965CE27;jsessionid=CC2B2FF77BE70ED30A59008DC57D82D7;jsessionid=BCDCBA568148BCE772D8C18BD107F409;jsessionid=87BCD66CB73E0442B3535617CE520F90;jsessionid=5BCCFF7DDB55C18A93D617B230EF8FE1;jsessionid=C61C92ECEC096E5F73A6467D8DA274CF;jsessionid=EADA0CE28D2FC934D1244007C82518A5;jsessionid=B86635C426B2E4A75ABFE02B35F923F1;jsessionid=17A59A8A3451698A2F8524FAC8D013FF;jsessionid=EB53E293554CA53257AEA37472CE3CB1;jsessionid=7091595676ED9C1671FF14DFCB7F0A3B;jsessionid=010F31CD061B7F405B2BAFDD7325CE8E (gene)

No studies found

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=DF855E1FCDC082CA178D4759DE591992;jsessionid=CEC07D6E3BD976C0A49BA3484965CE27;jsessionid=CC2B2FF77BE70ED30A59008DC57D82D7;jsessionid=BCDCBA568148BCE772D8C18BD107F409;jsessionid=87BCD66CB73E0442B3535617CE520F90;jsessionid=5BCCFF7DDB55C18A93D617B230EF8FE1;jsessionid=C61C92ECEC096E5F73A6467D8DA274CF;jsessionid=EADA0CE28D2FC934D1244007C82518A5;jsessionid=B86635C426B2E4A75ABFE02B35F923F1;jsessionid=17A59A8A3451698A2F8524FAC8D013FF;jsessionid=EB53E293554CA53257AEA37472CE3CB1;jsessionid=7091595676ED9C1671FF14DFCB7F0A3B;jsessionid=010F31CD061B7F405B2BAFDD7325CE8E